Holen Sie sich die Stockscreener-App
0.2415
1.77%
0.0042
Handel nachbörslich:
.24
-0.0015
-0.62%
Schlusskurs vom Vortag:
$0.2373
Offen:
$0.235
24-Stunden-Volumen:
739.85K
Relative Volume:
0.21
Marktkapitalisierung:
$55.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.23M
KGV:
-0.345
EPS:
-0.7
Netto-Cashflow:
$-11.54M
1W Leistung:
+0.50%
1M Leistung:
-10.56%
6M Leistung:
-67.45%
1J Leistung:
-67.14%
1-Tages-Spanne:
$0.235
$0.2469
1-Wochen-Bereich:
$0.2201
$0.26
52-Wochen-Spanne:
$0.2201
$2.10
Renovaro Inc Stock (RENB) Company Profile
Firmenname
Renovaro Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Vergleichen Sie RENB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.2415 | 54.80M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc Aktie (RENB) Neueste Nachrichten
RSI and MACD Indicate Shift in Renovaro Inc. SentimentConsistent Income Focused Trade List Analyzed - 선데이타임즈
Exit strategy if you’re trapped in Renovaro Inc.Smart Safety Strategy With Real Data Analysis - Newser
Advanced analytics toolkit walkthrough for Renovaro Inc.Free Triple Return Setup with Risk Control - Newser
How to recover losses in Renovaro Inc. stockSmart Forecast Signals from AI Models - Newser
Will Renovaro Inc. rebound enough to break evenReal-Time AI Entry Forecast Generator - Newser
Is Renovaro Inc. Stock Overbought or Oversold RSI Indicator AnalysisLow Drawdown Stock Screener with Analysis - Newser
Renovaro Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming3-Year Equity Summary With Setup Insights - Newser
How to read the order book for Renovaro Inc.AI Swing Strategy Signal Forecasting System - Newser
Why Renovaro Inc. stock attracts strong analyst attentionFree Real-Time Market Sentiment Tracking Tool - Newser
What the charts say about Renovaro Inc. todayTechnical Trade Plan with Entry Checklist - Newser
What’s the profit margin of Renovaro Inc.Breakout Stocks with Huge Upside - sisaissue.com
How institutional ownership impacts Renovaro Inc. stockFree Watchlist for Smart Swing Trading - Newser
Does Renovaro Inc. qualify in momentum factor screeningPredictive AI Engine for Smart Investing - Newser
Key resistance and support levels for Renovaro Inc.Predicted Market Direction Based on Momentum - Newser
Renovaro Inc. (NASDAQ: RENB) and the Strategic Convergence of AI, Biodefense, and Precision Medicine - AInvest
Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks | RENB Stock News - GuruFocus
Renovaro's Next-Generation AI Biodefense Technology Catches Defense Industry Attention - Stock Titan
Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks - The Globe and Mail
Renovaro Biosciences Granted Nasdaq Compliance Extension - TipRanks
Analyzing Renovaro Inc. with multi timeframe chartsEquity Performance Forecast Based on AI Models - Newser
How to monitor Renovaro Inc. with trend dashboardsFree Accurate Technical Trend Reversal Picks - Newser
What institutional investors are buying Renovaro Inc. stockTrack emerging stocks with high growth potential - Jammu Links News
Why is Renovaro Inc. stock attracting strong analyst attentionHigh-velocity gains - Jammu Links News
What are analysts’ price targets for Renovaro Inc. in the next 12 monthsOver 200% growth - Jammu Links News
What is Renovaro Inc. company’s growth strategyFree Consultation - Jammu Links News
How many analysts rate Renovaro Inc. as a “Buy”Achieve consistent high returns with low risk - Jammu Links News
What are Renovaro Inc. company’s key revenue driversCapitalize on market shifts with expert advice - Jammu Links News
Is Renovaro Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News
Is it the right time to buy Renovaro Inc. stockGet alerts on the hottest market movers - Jammu Links News
How does Renovaro Inc. compare to its industry peersFree Stock Movement Tracking - Jammu Links News
What makes Renovaro Inc. stock price move sharplyFree Investment Risk Control - Jammu Links News
How strong is Renovaro Inc. company’s balance sheetFree Stock Review For Consistent Profits - Jammu Links News
Can Renovaro Inc. recover in the next quarterChart Signal and Short-Term Forecast Tracker - Newser
When is Renovaro Inc. stock expected to show significant growthPre Market Forecasts That Work - Jammu Links News
Candlestick Reversal Detected on Renovaro Inc.’s ChartWeekly Watchlist of High Movers Released - metal.it
AI Just Got a Green Light from the White House–Here’s What That Means for Healthcare Stocks - Cantech Letter
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks - PR Newswire Canada
Is This a Bottoming Phase for Renovaro Inc.Wealth Building Stock Market Ideas Based on Momentum - beatles.ru
How did Renovaro's expenses impact profits in Q2 2025? - AInvest
Trading Bots Trigger Alerts on Renovaro Inc. ActivityReal Profit Trade Plan Suggestions Shared Widely - metal.it
Renovaro Inc. shares fall 1.59% after-hours following Maurice van Tilburg's resignation as chairman. - AInvest
Should I hold or sell Renovaro Inc. stock in 2025Daily Trading Review That Work - Jammu Links News
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector - USA Today
Elliott Wave Theory Predicts Pullback in Renovaro Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Renovaro BioSciences secures multiple U.S. patents in biomedical AI - TipRanks
Finanzdaten der Renovaro Inc-Aktie (RENB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):